Home | Business News | Browse by Publication | P | Pharma Marketletter

Neurochem launches Ph III European Alzhemed trial.

Publication: Pharma Marketletter
Publication Date: 26-SEP-05 		Format: Online
Delivery: Immediate Online Access
Full Article Title: Neurochem launches Ph III European Alzhemed trial.(Brief Article)

Article Excerpt
Canadian neurotherapeutics firm Neurochem has launched its European Phase III clinical trial of Alzhemed, its investigational product candidate for the treatment of Alzheimer's disease.

The multicenter, randomized, double-blind, placebo-controlled and parallel-designed European study will investigate the safety and efficacy of the agent in some 930 mild-to- moderate AD patients....

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.